The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

Share Price Information for Benchmark Holdings (BMK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 45.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.80 (4.082%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 45.00
BMK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Share Options

25 Jan 2018 11:54

RNS Number : 9419C
Benchmark Holdings PLC
25 January 2018
 

25 January 2018

 

BENCHMARK HOLDINGS PLC("Benchmark" or the "Company")

DIRECTOR SHARE OPTIONS

Benchmark Holdings plc announces that on 24 January 2018, and in accordance with the intention disclosed in its Annual Report and Accounts published on 23 January 2018, options over Ordinary Shares of 0.1 pence each ("Ordinary Shares") were granted to Malcolm Pye, Chief Executive Officer and Mark Plampin, Chief Financial Officer under the Company Share Option Plan (CSOP) in lieu of a cash bonus in respect of the 2017 financial year.

Options over a total of 500,000 Ordinary Shares were granted to Malcolm Pye and options over a total of 400,000 Ordinary Shares were granted to Mark Plampin. Following this grant, Malcolm Pye remains interested in 15,145,686 Ordinary Shares and holds options over a total of 500,000 Ordinary Shares in the Company, representing approximately 2.90% and 0.10% of Benchmark's existing issued share capital respectively. Mark Plampin remains interested in 536,686 Ordinary Shares and holds options over a total of 524,585 Ordinary Shares in the Company, representing approximately 0.10% and 0.10% of Benchmark's existing issued share capital respectively.

The options granted have a vesting period of three years, may be exercised up to the tenth anniversary of grant, have an exercise price of 69.5 pence per Ordinary Share, and are not subject to performance criteria.

 

Notification and public disclosure of a transactions by a persons discharging managerial responsibilities: 

 

Details of the person discharging managerial responsibilities / person closely associated 

 

a) 

 

Name 

 

Malcolm Pye

 

Reason for the notification 

 

a) 

 

Position/status 

 

Executive Director 

b) 

 

Initial notification/Amendment 

 

Initial

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

 

a) 

 

Name

 

Benchmark Holdings plc

b) 

 

LEI 

n/a

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a) 

 

Description of the financial instrument, type of instrument 

Identification code 

 

0.1p ordinary shares

ISIN: GB00BGHPT808 

b) 

 

Nature of the transaction 

 

Issue of share options under Company Share Option Plan (CSOP)

c) 

 

Price(s) and volume(s) 

 

 

Exercise price

 

Volume(s)

69.5 pence

500,000

d) 

 

Aggregated information

- Aggregated volume 

- Price 

 

Volume: 500,000

Price: Nil

e) 

 

Date of the transaction 

 

24 January 2018

f) 

 

Place of the transaction 

 

AIM Market, London Stock Exchange

 

 

 

 

Details of the person discharging managerial responsibilities / person closely associated 

 

a) 

 

Name 

 

Mark Plampin 

 

Reason for the notification 

 

a) 

 

Position/status 

 

Executive Director 

b) 

 

Initial notification/Amendment 

 

Initial

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

 

a) 

 

Name

 

Benchmark Holdings plc

b) 

 

LEI 

n/a

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a) 

 

Description of the financial instrument, type of instrument 

Identification code 

 

0.1p ordinary shares

ISIN: GB00BGHPT808 

b) 

 

Nature of the transaction 

 

Issue of share options under Company Share Option Plan (CSOP)

c) 

 

Price(s) and volume(s) 

 

 

Exercise price

 

Volume(s)

69.5 pence

400,000

d) 

 

Aggregated information

- Aggregated volume 

- Price 

 

Volume: 400,000

Price: Nil

e) 

 

Date of the transaction 

 

24 January 2018

f) 

 

Place of the transaction 

 

AIM Market, London Stock Exchange

 

 

 

ENDS

 

 

 

Benchmark Holdings plc

Tel: 020 7920 3150

Malcolm Pye, CEO

Ivonne Cantu, Investor Relations Director

Rachel Aninakwah, Communications

Numis

Tel: 020 7260 1000

Michael Meade / Freddie Barnfield (NOMAD)

James Black (Corporate Broking)

MHP

Katie Hunt / Reg Hoare / Alistair de Kare-Silver

Tel: 020 3128 8742 07551 170 451

benchmark@mhpc.com

 

Notes to Editors:

Benchmark challenges the status quo in aquaculture. Since 2000, Benchmark has consistently worked to build a technology-rich platform in the areas of genetics, nutrition, animal health and knowledge services, to serve its customers, helping them take control of their biological environment to improve yield and efficiency in a sustainable way. 

The Company has leading positions in its core markets and established R&D, manufacturing and distribution capabilities to serve all the major aquaculture markets. Benchmark operates in 27 countries in five continents and as at 30 September 2017, it employed 950 people. 

For further information on Benchmark please visit www.benchmarkplc.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHBAMBTMBATBJP
Date   Source Headline
6th Nov 20177:00 amRNSDirectorate Change
30th Oct 20177:00 amRNSLand-based Broodstock Facility Reaches Milestone
17th Oct 20177:00 amRNSNew Vaccine Facility Delivers First Production
10th Oct 20172:41 pmRNSHolding(s) in Company
21st Sep 20177:00 amRNSBlock Listing Six Monthly Return
8th Sep 20177:00 amRNSTrading Update
22nd Aug 20177:00 amRNSRenewal of Sales and Marketing Agreement
16th Aug 20177:00 amRNSLaunch of breakthrough purification system
28th Jul 20172:57 pmRNSDirector leave of absence
27th Jun 20177:02 amRNSHalf-year Report
19th Jun 20173:00 pmRNSNotice of Results
25th May 20177:00 amRNSTrading Update and Notice of Results
2nd May 20177:00 amRNSTotal Voting Rights
26th Apr 201710:54 amRNSDirector Dealings
3rd Apr 20174:32 pmRNSBlock Listing Six Monthly Return
9th Mar 20178:44 amRNSDirector Share Options and Issue of Shares
7th Mar 201710:39 amRNSResult of AGM
7th Mar 20178:00 amRNSContract Win
2nd Mar 20173:34 pmRNSHolding(s) in Company
1st Mar 20172:09 pmRNSHolding(s) in Company
23rd Feb 20177:00 amRNSHolding(s) in Company
22nd Feb 20174:35 pmRNSHolding(s) in Company
16th Feb 20177:45 amRNSDirector Dealings
24th Jan 20177:00 amRNSFinal Results
3rd Jan 20177:00 amRNSTotal Voting Rights
1st Dec 20167:00 amRNSDirector/PDMR Shareholding
29th Nov 20167:00 amRNSCapital Markets Day
25th Nov 20167:00 amRNSAppointment of Non-Executive Director
23rd Nov 20164:52 pmRNSHolding(s) in Company
26th Oct 20167:00 amRNSTrading Statement
12th Oct 20167:00 amRNSBlock Admission Application
10th Oct 201612:02 pmRNSBlock listing Interim Review
31st Aug 20167:00 amRNSBenchmark secures innovative new equine vaccine
12th Aug 201612:41 pmRNSHolding(s) in Company
11th Aug 20167:00 amRNSAcq of South American shrimp breeding programme
10th Aug 20163:37 pmRNSHolding(s) in Company
10th Aug 20161:40 pmRNSHolding(s) in Company
10th Aug 20161:33 pmRNSHolding(s) in Company
10th Aug 20161:29 pmRNSHolding(s) in Company
9th Aug 20163:26 pmRNSHolding(s) in Company
5th Aug 20167:00 amRNSPlacing of 47.3 million new ordinary shares
29th Jul 20167:00 amRNSDirectorate Change
19th Jul 20167:00 amRNSNew Seabass Vaccine Commences Field Trials
12th Jul 20167:00 amRNSBreeding & Genetics Contract Win
28th Jun 20167:00 amRNSHalf-year Report
3rd Jun 20167:00 amRNSChange of Adviser
27th May 20167:00 amRNSChange of Auditor
26th May 20167:00 amRNSTrading Update and Notice of Results
22nd Apr 201610:45 amRNSHolding(s) in Company
18th Apr 20169:40 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.